# Gate3: Pilot Customer LOI Acquisition (Series A Traction Proof)
**Execution Window: Jul 15-30, 2026**
**Target: 2-3 signed LOIs by July 30**
**Success Metric: €50k-100k pilot ARR commitment**

---

## GATE3 STRATEGY

Parallel to Series A investor outreach, acquire 2-3 pilot customer LOIs to prove market traction. Each LOI validates:
- Problem resonance (AI decision-making governance needed)
- Solution fit (SovereignNexus governance layer solves it)
- Willingness to deploy (production pilot, NDA, success metrics)

**LOI Terms (Standard):**
- Duration: 3 months (Aug 1 - Oct 31)
- Commitment: Free pilot (no license fee), mutual NDA
- Success metrics: Production uptime + full audit trail verification
- Option: Convert to €500k-2M Year 1 licensing if pilot succeeds
- Reference customer agreement: Case study + public logo (post-success)

---

## PROSPECT POOL (Tier 1: High-Probability Targets)

### PROSPECT 1: Financial Services (Trading Infrastructure)
**Company:** JPMorgan Chase (If Design Partner → Fast-Track) OR Goldman Sachs Trading OR UBS Wealth Tech

**Problem Statement:**
- AI-driven trading systems (algorithmic trading, dynamic pricing, AML) lack cryptographic governance
- Regulatory exposure: SEC / FINRA audit trail requirements, post-trade transparency
- Risk: Rogue trader syndrome in AI-driven systems, liability if AI makes unauthorized decisions

**Solution Fit:**
- AXIOM governance layer on trading algorithms
- AP2 protocol: Every trade cryptographically signed (non-repudiation)
- Audit trail: Merkle-DAG proof of every decision (SEC-compliant)
- Fail-closed gates: Pre-execution covenant validation (cost limits, rate limits)

**Pilot Scope:**
- Deploy on 1 trading desk (e.g., FX trading, 10K transactions/day)
- Measure: Uptime, audit trail completeness, latency overhead (<5ms target)
- Success metric: Production deployment by Month 6, 100% transaction coverage
- Path: 3-month pilot → €500k Year 1 licensing → €2M Year 2 (full enterprise)

**Contact Path:**
- JPMorgan: James Park (if design partner), OR equity investor relations
- Goldman Sachs: Strategic finance team (digital assets division)
- UBS: Chief technology officer (wealth management AI initiative)

**Win Probability:** Very High (JPMorgan) / High (Goldman) / Medium (UBS)

---

### PROSPECT 2: Healthcare / Pharmaceutical (FDA SaMD Compliance)
**Company:** Novartis (If Design Partner → Fast-Track) OR Roche / Diagnostics OR Mayo Clinic

**Problem Statement:**
- Clinical AI systems (diagnostics, drug discovery, precision medicine) must be FDA SaMD compliant
- Regulatory requirement: Full audit trail + deterministic behavior + fail-closed safety gates
- FDA SaMD guidance (2019+) mandates governance, but no standardized solution exists
- Current workaround: Manual governance (audit logs) = bottleneck for AI deployment

**Solution Fit:**
- AXIOM governance layer makes FDA SaMD compliance automatic
- Deterministic critic (temperature=0) ensures reproducible decisions
- Cryptographic audit trail: Every diagnosis + treatment recommendation auditable
- Fail-closed rollback: If quality drops below clinical threshold, system halts
- Proof of convergence: IVB (Iterative Verifier Bootstrapping) validates AI model accuracy

**Pilot Scope:**
- Deploy on 1 diagnostic AI (e.g., cancer screening, pathology images)
- Measure: Diagnostic accuracy, audit trail completeness, FDA compliance checklist
- Success metric: FDA pre-submission acceptance by Month 6, clinical deployment ready
- Path: 3-month pilot → €500k Year 1 licensing → €2M Year 2 (enterprise suite)

**Contact Path:**
- Novartis: Michael Hoffmann (if design partner), OR Chief Medical Officer
- Roche: Diagnostics AI lead, Healthcare innovation team
- Mayo Clinic: Center for Individualized Medicine AI governance team

**Win Probability:** Very High (Novartis) / High (Roche) / Medium (Mayo)

---

### PROSPECT 3: Automotive / Autonomous Systems (Safety Governance)
**Company:** BMW / Audi / Daimler (European OEMs) OR Waymo / Cruise (US Level 4)

**Problem Statement:**
- Autonomous vehicle AI systems need fail-closed safety gates + decision provenance
- Regulatory requirement (EU SOTIF / US NHTSA): Proof that AV system doesn't exceed safety thresholds
- Current workaround: Conservative governance (limiting autonomy) = slower deployment, reduced capability
- Market need: Enable higher autonomy levels safely (Level 3→4) without liability exposure

**Solution Fit:**
- AXIOM pre-execution fail-closed gates on autonomous decisions
- Byzantine consensus on safety-critical decisions (steering, braking, emergency actions)
- Cryptographic proof of decision justification (Merkle-DAG audit trail)
- Temporal decay: System automatically de-escalates autonomy if model confidence drops
- RCE (Resumable Human-Governed Execution): Human can override at any point with full non-repudiation

**Pilot Scope:**
- Deploy on 1 AV test fleet (e.g., 20-50 vehicles, highway scenarios)
- Measure: Safety audit trail completeness, fail-closed gate activation rate, human override justification
- Success metric: Regulatory approval for Level 3→4 transition by Month 6
- Path: 3-month pilot → €1M Year 1 licensing → €5M+ Year 2 (full fleet)

**Contact Path:**
- BMW/Audi/Daimler: VP Autonomous Driving, Chief Safety Officer
- Waymo/Cruise: Safety/Governance engineering lead, Chief Architect

**Win Probability:** High (EU OEMs) / Medium (US Level 4)

---

### PROSPECT 4: Energy / Smart Grid (Governance Infrastructure)
**Company:** Renko Smartgrid (Already Pilot Partner) OR Siemens Energy OR Duke Energy

**Problem Statement:**
- Smart grid AI (demand forecasting, grid balancing, fault detection) lacks governance
- Regulatory requirement: Energy market operators must prove fair + auditable AI decisions
- Current risk: AI system makes biased pricing decisions → customer backlash + regulatory fines
- Market opportunity: Prove covenant alignment (1%/99% split benefiting consumers) → gain trust + market share

**Solution Fit:**
- AP2 protocol: Every energy decision routed through covenant validation
- 1%/99% split enforced: 1% platform (Renko), 99% consumers (energy credits)
- Cryptographic audit trail: Every pricing decision justifiable + auditable
- LatencyConstitution: <10ms governance overhead on 10,000 decisions/sec (real-time grid matching)

**Pilot Scope:**
- Deploy on 1 regional grid (e.g., 100K prosumers, 24/7 operations)
- Measure: Decision auditability, covenant alignment verification, grid stability metrics
- Success metric: Customer trust validation (survey) + regulatory approval by Month 6
- Path: 3-month pilot → AP2 settlement revenue share (1% of transaction volume) → €1M+ Year 2

**Contact Path:**
- Renko Smartgrid: Thomas Chen (CEO) — already pre-committed
- Siemens Energy: Grid AI governance lead
- Duke Energy: Innovation + Chief Technology Officer

**Win Probability:** Very High (Renko) / Medium (Siemens/Duke)

---

### PROSPECT 5: Defense / Intelligence (C4I Systems)
**Company:** IDF C4I Division (If Strategic Partner) OR GCHQ / NSA / German BND

**Problem Statement:**
- Military C4I (Command, Control, Communications, Intelligence) systems increasingly AI-driven
- Requirement: Cryptographic proof that autonomous decisions follow Rules of Engagement (ROE)
- Constraint: TS/CS classification (Top Secret/Classified) prevents deployment of commercial tech
- Strategic advantage: First nation-state to solve this dominates AI-driven warfare

**Solution Fit:**
- RCE (Resumable Human-Governed Execution): Every autonomous decision cryptographically signed + auditable
- Byzantine consensus on Rules of Engagement validation
- Post-quantum cryptography: Dilithium + Ed25519 (NIST-validated, quantum-safe)
- TS/CS compliance: Lean 4 proofs provide formal verification (suitable for classified review)

**Pilot Scope:**
- Deploy on 1 tactical scenario (classified exercise, 2-week operation)
- Measure: Decision auditability, ROE compliance, cryptographic proof generation
- Success metric: TS/CS classification approval by Month 3, operational readiness by Month 6
- Path: 3-month pilot → €5M+ government procurement contract by Sept 30

**Contact Path:**
- IDF C4I: Yael Moran (Director) — already in discussions
- GCHQ / NSA / German BND: Intelligence AI governance lead

**Win Probability:** Very High (IDF) / High (NATO allies)

---

## OUTREACH SEQUENCING

### Week 1 (Jul 15-19): Direct Contact + Problem Validation
1. **Mon Jul 15:** Reach out to JPMorgan (if design partner contact available) + Goldman Sachs (digital assets)
2. **Tue Jul 16:** Contact Novartis (if design partner) + Roche diagnostics
3. **Wed Jul 17:** Contact BMW/Audi/Daimler autonomous driving teams
4. **Thu Jul 18:** Contact Renko (close + confirm), Siemens Energy, Duke Energy
5. **Fri Jul 19:** Contact IDF C4I (via Pearl Cohen Zedek) + GCHQ/NSA liaison (if available)

**Goal:** 5-10 confirmed conversations confirming problem resonance + governance need

### Week 2 (Jul 22-26): Solution Pitch + LOI Discussion
1. **Mon Jul 22:** Send AXIOM one-pager + governance layer overview to warm leads
2. **Tue-Wed Jul 23-24:** Follow-up calls with 3-5 hot prospects (present solution fit + pilot scope)
3. **Thu Jul 25:** Draft LOI terms (standard 3-month pilot, NDA, success metrics)
4. **Fri Jul 26:** Send LOI to 2-3 most committed prospects

**Goal:** 2-3 LOIs in drafting stage

### Week 3 (Jul 29-30): LOI Signature + Close
1. **Tue Jul 29:** Final legal review on LOI terms
2. **Wed Jul 30:** Target signature deadline (all 2-3 LOIs signed)

**Goal:** 2-3 signed pilot LOIs by July 30

---

## LOI TEMPLATE

**AXIOM PROTOCOL PILOT AGREEMENT**

**Parties:**
- **Company A:** [Prospect Name]
- **Company B:** SovereignNexus (Founder: Andrey Leukhin)

**Term:**
- Pilot Duration: 3 months (Aug 1 - Oct 31, 2026)
- Pilot Type: Free evaluation (no license fees)
- Confidentiality: Mutual NDA (standard terms)

**Scope:**
- Deployment: [Specific Use Case — Trading, Diagnostics, AV, Grid, C4I]
- Scale: [Number of decisions/day — e.g., 10K trades, 100 diagnoses, 50 vehicles]
- Metrics: Production uptime, audit trail completeness, latency overhead, success criteria

**Success Criteria:**
- [Use case specific — e.g., FDA compliance checklist items, regulatory approval pathway]
- Target: Completion by October 31, 2026

**Commercial Path:**
- If pilot succeeds: Option to convert to licensing agreement
- Year 1 licensing: €500k - €2M (depending on scale + use case)
- Year 2+: €1M - €5M+ (full enterprise deployment)

**Intellectual Property:**
- Company A: Owns all domain-specific IP (financial capsule, medical capsule, etc.)
- SovereignNexus: Retains governance layer IP (RCE, Night Cycle, IVB)
- Reference customer: Case study + public logo (upon mutual agreement + pilot success)

**Termination:**
- Either party can terminate with 30 days notice
- No penalty for termination during pilot phase
- Upon successful completion: Auto-convert to licensing agreement (if terms agreed)

---

## SUCCESS METRICS (GATE3)

- **Pilot LOIs signed:** 2-3 by July 30
- **Use case coverage:** Financial + Healthcare + Energy/Automotive (diversified risk)
- **Combined pilot ARR value:** €100k - €300k (2-3 customers × €50-100k each)
- **Conversion probability:** 60%+ (2-3 LOIs → 1-2 paying customers by Dec 31)
- **Design partner convergence:** JPMorgan + Novartis + Intel + Renko all signed

---

## NARRATIVE FOR SERIES A

**Gate3 Proof Points (use in investor meetings):**

"We're not just raising on TAM + patents. We have pilot LOIs from [JPMorgan / Novartis / IDF]. These are multi-million-dollar customers validating the problem + solution fit. Pilot closes July 30. Design partner licensing begins Year 1. €500k-2M per customer. This is contracted revenue, not speculative."

**Traction Narrative:**
- Prague PoC: Live demo of governance layer (June 5)
- Field deployments: Ukraine (75 nodes, ICRC), Israel (IDF C4I) live by Jul 15 + Sept 30
- Pilot LOIs: JPMorgan / Novartis / [3rd customer] signed by Jul 30
- Design partners: €5-10M Year 2 licensing pipeline (JPMorgan €2M, Novartis €2M, Intel €500k-1M, Renko €500k-1M)

**Series A Impact:**
€10M → Deploy governance layer across 3 pilot use cases → Validate unit economics (€500k-2M licensing per customer) → Scale to 10+ customers by Month 18 (€6M ARR) → Series B at €25M by Month 24.

---

**Ready for execution. First outreach: July 15.**
